Proteome Sciences PLC (LSE:PRM) - Overview

Stock Report

Proteome Sciences PLC PRM

Last Price
GBX5.56

Day Change
-0.32|-5.45%

As of 05/12/2016
10:10:48 GMT | GBX
Minimum 15 Minutes Delay.

Last Close5.88p
Day Range5.56 - 5.70
Mkt Cap16.09Mil
52-Wk Range5.00 - 23.94
Yield %0.00
ISINGB0003104196
Volume63,340
P/E-4.52
P/S6.53
P/CF-5.22

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Proteome Sciences PLC-0.09 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover2.141.561.88
Operating Profit-3.37-3.99-3.08
Net Profit-3.15-3.57-2.72
Reported EPS-1.62-1.69-1.23
Balance Sheet
Current Assets1.783.293.42
Non Current Assets5.275.015.31
Total Assets7.058.298.73
Current Liabilities9.008.869.22
Total Liabilities9.259.179.88
Total Equity-2.20-0.88-1.16
Cash Flow
Operating Cash Flow-3.20-3.96-2.92
Net Change in Cash-0.221.38-0.07
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-2.90-0.80--7.35---
2017-1.90-0.40--14.70---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/11/2016PurchaseMr. Roger McDowell5.002,000,000100,000.00
04/11/2016PurchaseJeremy Haigh5.00400,00020,000.00

Company Profile

Proteome Sciences PLC is engaged in providing applied proteomics, using high sensitivity proprietary techniques to detect and characterise differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications.
 

Sector

Diagnostics & Research

Market Position

1384 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(15/09/2016) "We have achieved good revenue growth over the first six months and expect this to continue for the full year"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-13.6213.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-77.83206.9680.66
Op Mrgn-163.71-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanChristopher Pearce
Chief Executive OfficerJeremy Haigh
Finance Director & Company SecretaryMr. Geoffrey Ellis
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.